Clinical Trial

AI Model for Early Gastric Cancer Diagnosis Using Endoscopic Imaging

Study acronym: XAI-EGC
Recruiting
View on ClinicalTrials.gov →
Summary
Early gastric cancer (EGC) is often difficult to detect accurately during endoscopic examination due to subtle morphological features and variability among endoscopists. Artificial intelligence (AI) has shown promise in improving diagnostic performance; however, most existing models lack interpretability and rely on single-modality imaging. This study aims to develop and evaluate an explainable multimodal artificial intelligence model for the diagnosis of early gastric cancer using endoscopic imaging. The model integrates features derived from white-light imaging and image-enhanced endoscopy, along with quantitative image features and clinical data, to improve diagnostic accuracy and provide interpretable decision support. The primary outcome is the diagnostic performance of the AI model for detecting early gastric cancer, evaluated by area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity. The results of this study are expected to provide evidence for the clinical utility of explainable AI in endoscopic diagnosis and support the development of reliable human-AI collaborative diagnostic systems.
Trial Details
NCT Number NCT07551466
Lead Sponsor The First Affiliated Hospital of Soochow University
Conditions Early Gastric Cancer
Enrollment 100 participants
Start Date 2026-05-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-24